Search results
Europe approves new multiple myeloma therapy CARVYKTI
Investing.com· 6 days agoThe European Commission has granted approval to CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for...
Biomarkers identified for successful treatment of bone marrow tumors
Medical Xpress· 1 day agoCAR T cell therapy has proven effective in treating various hematological cancers. In a clinical study, researchers from the University of Leipzig Medical Center and the Fraunhofer Institute ...
Study points to racial and social barriers that block treatment for multiple myeloma
Medical Xpress· 4 days agoAn analysis of data from three California health care organizations, published in Clinical Lymphoma,...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 1 day agoThe European Commission (“EC”) approved J&J’s JNJ Carvykti for earlier lines of treatment in...
Should You Be Bullish on Arcellx (ACLX)?
Insider Monkey via Yahoo Finance· 4 days agoBaron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be...
Vets exposed to Agent Orange at US bases denied VA compensation
USA Today· 1 day agoAs a young GI at Fort Ord in Monterey County, California, Dean Osborn spent much of his time in the...
Bristol Myers taps startup to boost cell therapy production
BioPharma Dive via Yahoo Finance· 5 days agoBristol Myers currently sells two so-called CAR-T cell therapies, Breyanzi for lymphoma and Abecma...
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 2 days agoIts third highest-grossing product, the multiple myeloma treatment Revlimid, already faces limited...
Lorna Kay Collins
The Ponca City News· 10 hours agoMercer, aged 69, passed away on April. Born on January 29, 1955, Lorna touched the lives of those around her with her strength, resilience, and...
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 3 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...
